DANIEL LEUNG to Humans
This is a "connection" page, showing publications DANIEL LEUNG has written about Humans.
Connection Strength
0.750
-
Advanced cystic fibrosis liver disease: Endovascular, endoscopic, radiologic, and surgical considerations. Pediatr Pulmonol. 2024 Sep; 59 Suppl 1:S115-S122.
Score: 0.026
-
Risk factors for more rapid progression of severe liver fibrosis in children with cystic fibrosis-related liver disease: A multi-center study validated by liver biopsy. Liver Int. 2023 06; 43(6):1277-1286.
Score: 0.023
-
Acute liver failure and unique challenges of pediatric liver transplantation amidst a worldwide cluster of adenovirus-associated hepatitis. Am J Transplant. 2023 01; 23(1):93-100.
Score: 0.023
-
Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease. Hepatology. 2023 02 01; 77(2):530-545.
Score: 0.023
-
Long-term follow-up and liver outcomes in children with cystic fibrosis and nodular liver on ultrasound in a multi-center study. J Cyst Fibros. 2023 03; 22(2):248-255.
Score: 0.022
-
Neurodevelopmental Outcomes in Children With Inherited Liver Disease and Native Liver. J Pediatr Gastroenterol Nutr. 2022 01 01; 74(1):96-103.
Score: 0.021
-
Hepatitis C in 2020: A North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper. J Pediatr Gastroenterol Nutr. 2020 09; 71(3):407-417.
Score: 0.020
-
Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Mini-Tabs Plus Ribavirin for Children Aged 3-11 Years with Hepatitis C Genotype 1a. Adv Ther. 2020 07; 37(7):3299-3310.
Score: 0.019
-
The Emergence of Elastography for Cystic Fibrosis Liver Disease. J Cyst Fibros. 2020 05; 19(3):339-341.
Score: 0.019
-
A Multidisciplinary Approach to Pretransplant and Posttransplant Management of Cystic Fibrosis-Associated Liver Disease. Liver Transpl. 2019 04; 25(4):640-657.
Score: 0.018
-
Obliterative Portal Venopathy Without Cirrhosis Is Prevalent in Pediatric Cystic Fibrosis Liver Disease With Portal Hypertension. Clin Gastroenterol Hepatol. 2019 09; 17(10):2134-2136.
Score: 0.017
-
Hepatitis B and C. Clin Liver Dis. 2018 11; 22(4):703-722.
Score: 0.017
-
Cystic Fibrosis-related cirrhosis. J Cyst Fibros. 2017 Nov; 16 Suppl 2:S50-S61.
Score: 0.016
-
Effects of Diagnosis by Newborn Screening for Cystic Fibrosis on Weight and Length in the First Year of Life. JAMA Pediatr. 2017 06 01; 171(6):546-554.
Score: 0.016
-
The intestinal microbiome and paediatric liver disease. Lancet Gastroenterol Hepatol. 2017 06; 2(6):446-455.
Score: 0.016
-
A 10-Year united network for organ sharing review of mortality and risk factors in young children awaiting liver transplantation. Liver Transpl. 2016 11; 22(11):1584-1592.
Score: 0.015
-
Hepatitis B immunity in the pediatric liver transplant population. Curr Opin Pediatr. 2016 10; 28(5):653-8.
Score: 0.015
-
50 Years Ago in TheJournal ofPediatrics: Macroscopic Cysts of the Pancreas in a Case of Cystic Fibrosis. J Pediatr. 2016 09; 176:133.
Score: 0.015
-
Drug-induced liver injury in children. Curr Opin Pediatr. 2015 Oct; 27(5):625-33.
Score: 0.014
-
Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease. Hepatology. 2015 Nov; 62(5):1576-83.
Score: 0.014
-
Baseline Ultrasound and Clinical Correlates in Children with Cystic Fibrosis. J Pediatr. 2015 Oct; 167(4):862-868.e2.
Score: 0.014
-
Reply to L'Huillier et al. Am J Transplant. 2015 Aug; 15(8):2277.
Score: 0.014
-
High prevalence of hepatitis B nonimmunity in vaccinated pediatric liver transplant recipients. Am J Transplant. 2015 Feb; 15(2):535-40.
Score: 0.013
-
Hepatitis C in the pediatric population: transmission, natural history, treatment and liver transplantation. World J Gastroenterol. 2014 Aug 28; 20(32):11281-6.
Score: 0.013
-
Angiosarcoma successfully treated with liver transplantation and sirolimus. Pediatr Transplant. 2014 Jun; 18(4):E114-9.
Score: 0.013
-
Unrecognized hepatitis B in pre-screened children with hematologic and oncologic conditions. Pediatr Blood Cancer. 2014 May; 61(5):865-8.
Score: 0.012
-
Cases in pediatric gastroenterology from The Children's Hospital of Philadelphia: a 2-year-old boy with diarrhea, failure to thrive, and hepatomegaly. Medscape J Med. 2009; 11(1):13.
Score: 0.009
-
Age- and ethnic-specific elevation of ALT among obese children at risk for nonalcoholic steatohepatitis (NASH): implications for screening. Clin Pediatr (Phila). 2009 Jan; 48(1):50-7.
Score: 0.009
-
Association Between Early Immunosuppression Center Variability and One-Year Outcomes After Pediatric Liver Transplant. Pediatr Transplant. 2025 Feb; 29(1):e70018.
Score: 0.007
-
Concordance of MASLD and NAFLD nomenclature in youth participating in the TARGET-NASH real-world cohort. Hepatol Commun. 2024 Nov 01; 8(11).
Score: 0.007
-
Identification, mapping, and self-reported practice patterns of village doctors in Sitakunda subdistrict, Bangladesh. J Glob Health. 2024 Sep 13; 14:04185.
Score: 0.006
-
Randomized double-blind placebo-controlled study to evaluate the effect of long-acting mesalamine on postinfectious irritable bowel syndrome with diarrhea. Neurogastroenterol Motil. 2024 Oct; 36(10):e14889.
Score: 0.006
-
Sofosbuvir-velpatasvir in children 3-17 years old with hepatitis C virus infection. J Pediatr Gastroenterol Nutr. 2024 Jun; 78(6):1342-1354.
Score: 0.006
-
SHIFTing goals in cystic fibrosis-managing extrapulmonary disease in the era of CFTR modulator therapy; Proceedings of the International Shaping Initiatives and Future Trends (SHIFT) Symposium. Pediatr Pulmonol. 2024 Jun; 59(6):1661-1676.
Score: 0.006
-
Educating pediatric gastroenterology fellows: Milestones, EPAs, & their application within a new educational curriculum. J Pediatr Gastroenterol Nutr. 2024 Jun; 78(6):1213-1216.
Score: 0.006
-
Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline. Hepatology. 2025 Jan 01; 81(1):358-379.
Score: 0.006
-
Imaging-based noninvasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline. Hepatology. 2025 Feb 01; 81(2):725-748.
Score: 0.006
-
Estimating risk of prolonged mechanical ventilation after liver transplantation in children: PROVE-ALT score. Pediatr Transplant. 2024 Feb; 28(1):e14623.
Score: 0.006
-
The Multidisciplinary Pediatric Liver Transplant. Curr Probl Surg. 2023 11; 60(11):101377.
Score: 0.006
-
Prospective study of quantitative liver MRI in cystic fibrosis: feasibility and comparison to PUSH cohort ultrasound. Pediatr Radiol. 2023 10; 53(11):2210-2220.
Score: 0.006
-
Surgical Management and Outcomes of Patients with Multifocal Hepatoblastoma. J Pediatr Surg. 2023 Sep; 58(9):1715-1726.
Score: 0.006
-
Upper airway microbiota development in infants with cystic fibrosis diagnosed by newborn screen. J Cyst Fibros. 2023 07; 22(4):644-651.
Score: 0.006
-
Heterogeneous liver on research ultrasound identifies children with cystic fibrosis at high risk of advanced liver disease. J Cyst Fibros. 2023 07; 22(4):745-755.
Score: 0.006
-
A new chapter in an evolving pandemic: Successful pediatric liver transplantation with SARS-CoV-2+ donors. Pediatr Transplant. 2022 12; 26(8):e14407.
Score: 0.006
-
Health-related Quality of Life in a Prospective Study of Ultrasound to Detect Cystic Fibrosis-related Liver Disease in Children. J Pediatr Gastroenterol Nutr. 2022 11 01; 75(5):635-642.
Score: 0.006
-
A Case Series of Children with Acute Hepatitis and Human Adenovirus Infection. N Engl J Med. 2022 08 18; 387(7):620-630.
Score: 0.006
-
Impact of long-term administration of maralixibat on children with cholestasis secondary to Alagille syndrome. Hepatol Commun. 2022 08; 6(8):1922-1933.
Score: 0.006
-
Our evolution in the treatment of hepatic artery and portal vein thrombosis in pediatric liver transplantation: Success with catheter-directed therapies. Pediatr Transplant. 2022 09; 26(6):e14306.
Score: 0.006
-
Association between stool consistency and clinical variables among infants with cystic fibrosis: Findings from the BONUS study. J Cyst Fibros. 2022 09; 21(5):830-836.
Score: 0.006
-
Risk of variceal hemorrhage and pretransplant mortality in children with biliary atresia. Hepatology. 2022 09; 76(3):712-726.
Score: 0.005
-
Global landscape of SARS-CoV-2 genomic surveillance and data sharing. Nat Genet. 2022 04; 54(4):499-507.
Score: 0.005
-
Predictors of survival following liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma: Experience from the Society of Pediatric Liver Transplantation (SPLIT). Am J Transplant. 2022 05; 22(5):1396-1408.
Score: 0.005
-
Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric Cystic Fibrosis. J Cyst Fibros. 2022 03; 21(2):236-242.
Score: 0.005
-
Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequences. BMC Microbiol. 2021 09 15; 21(1):247.
Score: 0.005
-
The use of tracheostomy to support critically ill children receiving orthotopic liver transplantation: a single-center experience. Pediatr Transplant. 2022 Feb; 26(1):e14140.
Score: 0.005
-
Epidemiology and long-term outcomes of cytomegalovirus DNAemia and disease in pediatric solid organ transplant recipients. Am J Transplant. 2022 01; 22(1):187-198.
Score: 0.005
-
Gastrointestinal Factors Associated With Hospitalization in Infants With Cystic Fibrosis: Results From the Baby Observational and Nutrition Study. J Pediatr Gastroenterol Nutr. 2021 09 01; 73(3):395-402.
Score: 0.005
-
Integration of a dedicated management protocol in the care of pediatric liver cancer: From specialized providers to complication reduction. J Pediatr Surg. 2022 Aug; 57(8):1544-1553.
Score: 0.005
-
Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Children With Chronic HCV: Part 2 of the DORA Study. Hepatology. 2021 07; 74(1):19-27.
Score: 0.005
-
Severe Acute Respiratory Syndrome Coronavirus-2 Infection in Children With Liver Transplant and Native Liver Disease: An International Observational Registry Study. J Pediatr Gastroenterol Nutr. 2021 06 01; 72(6):807-814.
Score: 0.005
-
Biomarkers for liver disease in urea cycle disorders. Mol Genet Metab. 2021 06; 133(2):148-156.
Score: 0.005
-
Operational Definitions for Chronic Liver Disease Manifestations and Recurring Clinical Events in Biliary Atresia. J Pediatr Gastroenterol Nutr. 2021 04 01; 72(4):584-591.
Score: 0.005
-
Liver transplant in a recently COVID-19 positive child with hepatoblastoma. Pediatr Transplant. 2021 08; 25(5):e13880.
Score: 0.005
-
The pediatric solid organ transplant experience with COVID-19: An initial multi-center, multi-organ case series. Pediatr Transplant. 2021 05; 25(3):e13868.
Score: 0.005
-
Comparison of Recommendations for Treatment of Chronic Hepatitis C Virus Infection in Children and Adolescents: A Position Paper of the Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2020 05; 70(5):711-717.
Score: 0.005
-
Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency. JCI Insight. 2020 02 27; 5(4).
Score: 0.005
-
Heterogeneous Liver on Research Ultrasound Identifies Children with Cystic Fibrosis at High Risk of Advanced Liver Disease: Interim Results of a Prospective Observational Case-Controlled Study. J Pediatr. 2020 04; 219:62-69.e4.
Score: 0.005
-
Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure. Nat Med. 2020 02; 26(2):215-221.
Score: 0.005
-
Liver Ultrasound Patterns in Children With Cystic Fibrosis Correlate With Noninvasive Tests of Liver Disease. J Pediatr Gastroenterol Nutr. 2019 09; 69(3):351-357.
Score: 0.005
-
Accuracy of Transient Elastography Data Combined With APRI in Detection and Staging of Liver Disease in Pediatric Patients With Cystic Fibrosis. Clin Gastroenterol Hepatol. 2019 11; 17(12):2561-2569.e5.
Score: 0.004
-
Pulmonary findings in infants with cystic fibrosis during the first year of life: Results from the Baby Observational and Nutrition Study (BONUS) cohort study. Pediatr Pulmonol. 2019 05; 54(5):581-586.
Score: 0.004
-
Hepatic Steatosis Is Prevalent Following Orthotopic Liver Transplantation in Children With Cystic Fibrosis. J Pediatr Gastroenterol Nutr. 2019 01; 68(1):96-103.
Score: 0.004
-
MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis. Hepatology. 2018 12; 68(6):2301-2316.
Score: 0.004
-
Pancreatic Enzyme Replacement Therapy Use in Infants With Cystic Fibrosis Diagnosed by Newborn Screening. J Pediatr Gastroenterol Nutr. 2018 04; 66(4):657-663.
Score: 0.004
-
Erythropoietic Protoporphyria: Initial Diagnosis With Cholestatic Liver Disease. Pediatrics. 2018 04; 141(Suppl 5):S445-S450.
Score: 0.004
-
Dried Blood Spots for Measuring Vibrio cholerae-specific Immune Responses. PLoS Negl Trop Dis. 2018 01; 12(1):e0006196.
Score: 0.004
-
Variceal Hemorrhage and Adverse Liver Outcomes in Patients With Cystic Fibrosis Cirrhosis. J Pediatr Gastroenterol Nutr. 2018 01; 66(1):122-127.
Score: 0.004
-
Primary prophylaxis of variceal bleeding in children and the role of MesoRex Bypass: Summary of the Baveno VI Pediatric Satellite Symposium. Hepatology. 2016 Apr; 63(4):1368-80.
Score: 0.003
-
Hepatitis D in Children. J Pediatr Gastroenterol Nutr. 2015 Sep; 61(3):271-81.
Score: 0.003
-
Standardization of Research-Quality Anthropometric Measurement of Infants and Implementation in a Multicenter Study. Clin Transl Sci. 2015 Aug; 8(4):330-3.
Score: 0.003
-
Starting an academic career and starting a family: challenges and some potential solutions. J Pediatr. 2014 Sep; 165(3):430-1.
Score: 0.003
-
Early attained weight and length predict growth faltering better than velocity measures in infants with CF. J Cyst Fibros. 2014 Dec; 13(6):723-9.
Score: 0.003
-
Use of allopurinol in children with acute lymphoblastic leukemia to reduce skewed thiopurine metabolism. Pediatr Blood Cancer. 2014 Jun; 61(6):1114-7.
Score: 0.003
-
NASPGHAN practice guidelines: Diagnosis and management of hepatitis C infection in infants, children, and adolescents. J Pediatr Gastroenterol Nutr. 2012 Jun; 54(6):838-55.
Score: 0.003